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Abstract 
Background: The relationship between affective disorder and symptoms of anxiety and depression is very complex. 
Although a variety of self-report measures are beginning to be utilized to access anxiety and depression in patients 
with affective disorder. Also evidence shows that individuals with affective disorder experience better functioning 
and reduced symptom if they follow recommended psychiatric treatment. Learning to live with a continuous, 
episodic illness is a huge challenge for people with bipolar disorder and their family.  
Objective: The relationship between affective disorder and symptoms of anxiety and depression is very complex. 
Although a variety of self-report measures are beginning to be utilized to access anxiety and depression in patients 
with affective disorder. Also evidence shows that individuals with affective disorder experience better functioning 
and reduced symptom if they follow recommended psychiatric treatment 
Methods: The study involved 80 patients (32 males, 48 females) with an average age 44,5 years, hospitalized in the 
Psychiatric Hospital in Skopje and the Department of Psychiatry of Clinical Hospital in Tetovo, with a clinical 
diagnosis of affective disorder. The diagnosis of affective disorder is set against the classification DSM – V 
(Diagnostic and Statistical Manual of Mental Disorder). All subjects were under adequate psychopharmacological 
treatment. The Hamilton Anxiety Rating Scale (HAM-A), Hamilton Depression Rating Scale (HAM-D) and 
Treatment Motivation Questionnaire (TMQ) were applied to the entire population. 
Results: From the results it is evidenced that the patients with affective disorder have higher scores on the HAM-A 
and HAM-D. The correlation was positively significant at the level of 0.01. Also there was significant relationship 
between treatment motivation and the type of disorder (F, 2, 77 = 11.902; p<0.00). 
Conclusions: Depression and anxiety are common in patients with affective disorder and can interfere with their 
response to treatment.  
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Introduction 
Bipolar disorder, also know as manic-depressive illness, is a brain disorder that causes unusual shift in a person's 
mood, energy and ability to function(Birchwood, 2000). The mood episodes associated with the disorder persist 
from days to weeks or longer and can be dramatic witjh period of being overly high and irritable to periods of 
persestent sadness and hopelessness.  
 
Sever changes in behavior go along with mood changes. These periods of hoghs and lows, called episodes often 
recurring over time or they may occur together in a so-called mixed state. Often people with bipolar disorder 
experience periods of normal mood in between mood episodes (Verdoux and Bourgeois, 1993).. 
 
This kind of disorder is characterized by alternating manic episodes in which the individual feels abnormally euphric, 
optimistic,full with emergy, sometimes irritable, engages in multiple activities, may develop thinking that is out of 
step with reality and depressive periods in which the individual feels sad, hopeless, guilty and sometimes suicidal. In 
fact, there is some evidence that depression phase is much more commom than periods of mania in this illness. 
Bipolar depression can be much more bistressing than mania and because of the risk of suicide, is potentially more 
dangerous. Mixed status, where both manic or hypomanic symptoms and depressive symptoms occur at the same 
time are ofen presented at the patients. 
 
It is known that changes are a normal part of life. However, with bipolar disorders, the awings are more extreme. 
They become so intense, that the person does not realize that he/she is not behavings normally or the person suffers 
as much from depression that he/she is paralyzed and overwhelmed by suicidal thoughts. Also a large number of 
studies report that individuals who have experienced affective disorder often feel depressive and anxiety. These 
disturbances can be seen before to the development of psychosis (Neale et al., 2005) and also appear to be 
implicated in relapse. Depression was found, in up to 50-60% of patients with affective disorder (Johnson, 2008). 
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The symptoms of depression in affective disorder vary slightly from typical profile of primary depression. The 
patient shows the following symptoms: depressed mood, markedly diminished interest or pleasure, significant 
weight loss or gain or appetite disturbance, insomnia, psychomotor agitation or retardation, inappropriate guilt, 
diminished ability to think or concentrate or indecisiveness, or recurring thoughts of death including suicidal 
ideation. In people with affective disorder, depression is associated with a poor quality of life as well as lower 
survival. 
 
Anxiety was also frequently reported in patients with affective disorder (Cosoff and Smith, 1980). The presence of 
panic attacks, significant anxiety, nervousness, worry or fearful avoidance of activities in addition to periods of 
depression and mania or both together. Bipolar disorder and anxiety has been associated with decreased functioning 
and quality of life. 
 
Depression and anxiety are two of the prominent emotional states seen clinically and studied by researchers. They 
are manifested variety of symptoms among individuals and have increased effort by objectively their evaluations 
with use of such instruments as the Beck Depression Inventory (BDI), Hamilton Rating Scale (HAMD or HAMA) 
and Sung. In general, these studies argue against the contention that measures of depression, anxiety and affective 
disorder are dependent. 
 
On the other hand, empirical evidence shows that individuals with affective disorder have better functioning and 
reduced symptoms if they follow recommended psychiatric treatment (Perkins, 1999; Kampman and Lehtinen, 
1999). Understanding and measuring the components of treatment motivation in people with affective disorder are 
complicated by the features of their psychopathology, as well as the kinds of interventions they tend to receive. In 
patients with major mood disorder, depressive symptoms can interfere with internal motivation. Patients with manic 
symptoms interfere with external treatment motivation. Treatment motivation has been predictive of adherence to 
medications (Frank and Goering, 1994; Compton and Nemeroff, 2000).      
 
Treatment of bipolar disorder depends upon the specific forms of behavioral disorder. Medication is the most 
effective treatment in affective disorder. A combination of mood stabilizing agents with anxiety medications and 
antidepressants may be used to regulate manic or depressive episodes.  
Against this backdrop, three objectives are raised for this study: 
1. To determine the relationship between anxiety and affective disorder among the clinical subjects; 
2. To investigate the relationship between depression and affective disorder among the clinical subjects; 
3. To establish the treatment motivation in patients with affective disorder. 
 
Methods 
The cross-sectional study included 80 (32 males and 48 females) consecutive patients with affective disorder. The 
mean age of patients was 44.5 years. These patients are regularly attended at the Psychiatric Hospital in Skopje and 
the Department of Psychiatry of Clinical Hospital in Tetovo which are part of the public National Health Service 
system. After their appointment with their psychiatrists, patients were invited to participate in this study. Also these 
subjects are not asking part in any clinical trial. No patients refused to participate. Affective disorder was diagnosed 
according to DSM-V diagnostic criteria (APA, 2013). Demographic and clinical data obtained. The patients have 
been treated with lithium carbonate, antipsychotics, antidepressants and anxiety medications. The patients were 
assessed to participate with the scales after start of treatment. All subjects received verbal and written information 
from the investigators about the purpose and design of the study. 
 
Ethical Permission Guiding for Study  
Ethical approval was obtained and informed consent obtained from all the participants prior to the study. 
 
Instruments  
The instruments were used to collect data for the study. All the instruments do have high validity which makes them 
relevant and useful for the study. 
 
Anxiety 
Anxiety was evaluated with Hamilton Rating Scale (HAMA). This is a 14-item, clinician rated scale that includes 
both psychological and somatic symptoms of anxiety and can been completed in 10-20 minutes (Hamilton, 1995). 
The respondent is asked to rate how much he or she has been bothered by each symptoms over the past week on a 5-
point scale ranging from 0 to 4. The items are summed to obtain a total score that can range from 0 to 56. If the 
score is to eight points there are no indications of anxiety. Mild anxiety is suggested if the score is between 9 to 16 
points. HAMA suggests moderate anxiety symptoms of the score is between 17 and 24 and severe anxiety symptoms 
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if the score is between 25 and 56. The scale has been found to be valid and reliable, with Cronbach's alpha of 0.753. 
 
Depression  
Hamilton Rating Scale for Depression (HAMD) is regarded as the ”gold standard” for assessing severity of 
depressive symptoms in patients with mood disorders (Hamilton, 1995). The 17-item version was employed in the 
present study. In this version eight items are scored on a 5-point scale, ranging from 0 to 4; total scores range from 0 
to 50. The standard cutoffs are:  0-8 indicates no depression symptoms; 9-16 indicates mild depression; 17-24 
indicates moderate depression and 20-50 indicates severe depression. The validity of the scale was Cronbach's alpha 
was 0.834.  
 
Treatment Motivation 
Treatment Motivation was measured using the Treatment Motivation Questionnaire (TMQ). The Treatment 
Motivation Questionnaire (TMQ) is a 26-item scale that was originally designed to measure dimensions of the 
person's motivation for treatment. TMQ response categories comprise a seven-point Linker scale, ranging from 
1(not at all true) to 7(very true). Cronbach's reliability for TMQ was 0.742. 
 
Procedure and Data Analysis 
All the participants completed the three questionnaires HAMA, HAMD, TMQ and demographic variables (age, 
gender). The statistical analyses were conducted using Statistical Package for the Social Sciences (SPSS) version 17. 
Correlation analysis (one-way ANOVA) was employed to understand the relationships between anxiety, depression 
and motivation for treatment in patients with affective disorder. 
 
Results 
80 clinical subjects were selected for the study, 40% (n=32) of the patients were males while 60% (n=48) were 
females. Most of the patients with affective disorder had middle and high level depression. HAMD scores ranged 
from 0 to 50. After scores of the entire samples were subdivide into three categories: 20% of patients had mild 
depressive symptoms (score 9-16), 51% had moderate depressive symptoms (score 17-24) and 29% had severe 
symptoms (score 25-50). The level of anxiety was also high among participants. HAMA scores ranged from 0 to 56. 
Upon subdividing the scores into three categories: 18% of patients had mild anxiety (score 9-16), 51% had moderate 
anxiety (scores 17-24) and 31% had severe anxiety symptoms (score 25-56). 
As shown in table 1 subject with history of affective disorder scored higher both in HAMA and HAMD. The mean 
HAMD score in patients was 23.00 points, while the mean HAMA score was 20.00. Also our patient group had high 
motivation for treatment. The mean TMQ score was 114.00 points.  
 
Table1.  Mean (standard deviation) HAMD, HAMA and TQM scores for patients with affective disorder 
Measure HAMD HAMA TQM 
Mean 23.00 20.00 114.00 
Standard Deviation 5.154   7.25  16.59 
Mode 27.00 20.00  96.42 
Variance 26.67 52.69 275.46 
Minimum 13.00  6.00  73.00 
Maximum 44.00 32.00 154.00 
N 80 80 80 
 
Obtained results confirm that depression and anxiety are present in all patients with affective disorder. A one-
way ANOVA revealed a significant main effect of group on the depression scale (F, 2, 77 = 17.904, p=0.000). Also 
from table 2 we can see that with one-way ANOVA revealed a significant effect of group on the anxiety scale (F, 
2, 77 = 22.403, p=0.000). With the same statistical method we observed that patients with affective disorder had 
been motivated to attend and adhere to treatment (F, 2, 77 = 11.902, p=0.000). 
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 Table2. Summary of One way ANOVA between depression, anxiety and motivation for treatment 
 
ANOVA     
  
Source of Variation 
 
Sum of Squares 
 
df 
 
Mean Square 
 
F 
 
Sig. 
Depression Between Groups 668.889 2 334.445 17.904 .000 
 Within Groups 1438.311 77 18.679   
 Total 2107.200 79    
Anxiety Between Groups 1531.256 2 765.628 22.403 .000 
 Within Groups 2631.494 77 34.175   
 Total 4162.750 79    
Motivation Between Groups 5138.642 2 2569.321 11.902 .000 
 Within Groups 16622.908 77 215.882   
 Total 21761.550 79    
 
 
From the Figure 1 is clear that patients with affective disorder manifested symptoms of anxiety and depression 
during the illness. Treatment depends upon correctly identifying the source of anxiety and depression, so at the same 
time all participants had increasing motivation to take medication. 
 
 
Figure1. The correlation between HAMD, HAMA and TMQ 
 
Discussion 
Most people feel anxious at times and have their ups and downs. It is natural for a mood to change anxiety level to 
be higher when a stressful or difficult event occurs. 
 
But some people experience feelings of anxiety or depression or suffer mood swings hat are so severe and 
overwhelming that there interfere with personal relationships, job responsibilities and daily functioning. These 
people may be suffering from an anxiety disorder, depressive disorder or both (Fenton. and McGlashan, 2004; 
Swanson et al., 2006).  
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It is uncommon for someone with anxiety disorder, to also suffer from bipolar disorder. Many people with affective 
disorder suffer front at least one anxiety episodes at some point in their lives (Gross, 1999). 
 
In relation to the period prior to acute psychosis, there is a consensus that majority of individuals experience 
symptoms of anxiety, depression and irritability up to 4 weeks prior to the appearance of positive psychotic 
symptoms (Suslow et al., 2003). These findings of emotional disturbance prior to positive psychotic symptoms 
suggest that there is an interaction between emotion dysfunction and psychotic symptoms. 
 
Our data in line with previous report showing higher prevalence of anxiety and depressive symptoms in patients 
with affective disorder to comparisons with controls (Gross, 1998). The precise explanation at these symptoms in 
patients with affective disorder has not been fully established, but some studies have suggested that depression 
severity is related with the progression of the disease, while other studies have described depression since the early 
state of the depressive disorder (Lenroot, Bustillo, Lauriello.and Keith, 2003). More than half of these patients had 
depressive symptoms prior to an acute relapse of their psychosis, perhaps suggesting that emotional disturbance was 
implicated in their relapse. 
 
In the current study HAMA and HAMD correlated strongly with affective disorder. We found higher scores in the 
HAMD then HAMA in clinical patients with affective disorder. In our study anxiety and depression associated with 
disease severity, advance disease stages and worse performance in daily activities. Now is clear that the explanation 
of anxiety and depression in affective disorder relied on psychopathological aspects (Snaith, 1996). It is possible that 
the increased depressive and anxiety level in affective disorder is related with the psychological consequences 
resulting from progressive psychological deficit and hence, limitations imposed by affective disorder. 
 
On the other hand, the treatment motivation among people with affective disorder has been shown to improve 
clinical outcomes, such as psychosocial functioning, reduced psychiatrist and emotional symptoms such as anxiety 
and depression. There is currently limited understanding of the psychological mechanisms underlying motivation for 
treatment among people with affective disorder. Treatment motivation could be key factor associated with 
persistence in psychosocial treatment and taking prescribed psychiatric medications (Bach.and Hayes, 2000; Olfson 
et al., 2000; Ryan, Plant and Malley, 1995). The term treatment motivation does not only refer to maintain a 
psychotropic medication, but also to participating in the array of mental health services available to people with 
affective disorder (Nageotte, Sullivan, Duan. and Camp, 2007). 
 
During our research we found that our patients group had been more motivated to mental health treatment due to 
psychiatric stabilization and recovery that comes with the older years. Maybe motivation to mental health treatment 
leads to better out comes such as a decrease in symptoms and better global functioning. Treatment motivation also 
reduces costs and hospitalization in mental health system. 
 
It seems clear that patients with affective disorder who have depressive and anxiety symptoms deserve early and 
robust intervention. This is very important, because as depression and anxiety may negatively impact quality of life 
of the person with affective disorder, the recognition and treatment of these psychopathological syndromes are of 
paramount importance for a better patient outcome and improved quality of life. 
 
Conclusions 
To our knowledge this is one of the first studies in which the relationships between the affective disorder and the 
symptoms of depression and anxiety have been investigated in our population. In this study we found that symptoms 
of affective disorder are strongly associated with anxiety and depression. 
 
In this study significant correlation were noted between: (1) the HAMD and affective disorder; (2) the HAMA and 
affective disorder. So these results indicate that the HAMD and HAMA include symptoms of general emotionality. 
Upon closer examinations of the types of question in the two questionnaires studied here, it is also noted that 
HAMD and HAMA include questions that relate to somatic complaints and the general symptoms associated with 
over emotionality. 
 
The majority of our research is that patients with affective disorder had been motivated for better mental health 
treatment. They try to recognize the importance of psychiatric medications conductions with psychosocial treatment. 
In conclusion, the mental state affective disorder is strongly associated with depressive and anxiety symptoms 
among participants in this clinical population. The clinical validity of these findings is strength by the relationships 
of these symptoms to self-reported lifetime mental disorders and use at the health services for psychiatric reasons. A 
combination of medication and psychotherapy is most helpful. The role of psychological treatments is to help person 
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cope with the experience of bipolar disorder and its effects. Better outcomes can be achieved with tsome kind of 
additional therapies, like cognitive behavioral therapy (looking at how the person thinks and what he/she does, 
which can ease depression and anxiety; interpersonal or social rhythms therapy focuses on the roles of relationship 
difficulties and changes in daily patterns for those with bipolar disorder. At the same time when families are kept 
involved, patients adjust more easily, are more likely to make good decisions about their treatment and have a better 
quality of life. Developing a balanced lifestyle can also help person to minimize the risk of relapse.  
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